Clinical Trial Update: Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis [Phase 3]

View source ↗

Summary

An extension study in adults with atopic dermatitis to assess the safety and efficacy of pimecrolimus in a Phase 3 trial, sponsored by Novartis; the study is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Pimecrolimus (pimecrolimus)

Snippet

Sponsor: Novartis | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED